Light Chain (AL) Amyloidosis
Metabolic·MeSH: Amyloidosis
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Birtamimab | PROTHENA CORP PUBLIC LTD CO (PRTA) |
Phase 1(1)
| Drug | Company |
|---|---|
| nxc-201 | Immix Biopharma, Inc. (IMMX) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| nxc-201 car-t | Axcella Health Inc. (AXLA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Light Chain (AL) Amyloidosis?
BioSniper tracks 3 drugs in development for Light Chain (AL) Amyloidosis across 3 companies.
How many clinical trials target Light Chain (AL) Amyloidosis?
There are 2 clinical trials targeting Light Chain (AL) Amyloidosis tracked by BioSniper.
Deep-dive into Light Chain (AL) Amyloidosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis